To further assess the relationship between IL-32 and TLRs in myeloma patients we compared TLR gene expression in MM primary cells with high- (n=80) or no/low expression of IL-32 (n=712) (IA13 CoMMpass dataset, cutoff: log2cpm>1.52, upper 10th percentile vs. lower 90th percentile). The gene discussed is IL32; the disease is Miyoshi myopathy.